Patient retention is a critical factor in the success of clinical trials, yet dropout rates have … Why Patient Dropout Rates Are Rising in Clinical ResearchRead more
Case Studies & Trends
Beginner explainers, tools walkthroughs, glossaries, and FAQs.
How Poor Investigator Engagement Slows Trial Progress
Clinical trials are complex undertakings that rely heavily on the active participation and engagement of site … How Poor Investigator Engagement Slows Trial ProgressRead more
Why Clinical Trial Sites Are Burned Out and What Pharma Can Do
Clinical trial sites in the United States are under mounting pressure, with recent surveys showing that … Why Clinical Trial Sites Are Burned Out and What Pharma Can DoRead more
Why Many Drugs Fail Due to Poor Market Fit in the U.S. Pharmaceutical Market
The development of a new pharmaceutical drug represents one of the most resource-intensive processes in modern … Why Many Drugs Fail Due to Poor Market Fit in the U.S. Pharmaceutical MarketRead more
Why Many Pharma Launches Miss Revenue Targets in the U.S. Market
Roughly half of new drug launches in the United States fail to meet first-year revenue expectations. … Why Many Pharma Launches Miss Revenue Targets in the U.S. MarketRead more
How Patient Engagement Improves Clinical Trial Success
Patient engagement is emerging as a critical factor in the success of clinical trials, particularly in … How Patient Engagement Improves Clinical Trial SuccessRead more
Why Clinical Trial Diversity Is a Growing Challenge
Clinical trials form the scientific backbone of drug approval in the United States. Every therapy that … Why Clinical Trial Diversity Is a Growing ChallengeRead more
Top 5 Reasons Biotech Companies Fail to Scale
Biotechnology has emerged as one of the most innovation-driven sectors in healthcare. Advances in gene therapy, … Top 5 Reasons Biotech Companies Fail to ScaleRead more
How Data Silos Hurt Pharma Innovation
Over 70% of pharmaceutical R&D data in the United States remains siloed, according to PhRMA (https://phrma.org). … How Data Silos Hurt Pharma InnovationRead more
Why Many Drugs Fail Despite Positive Trial Results
Over 90 percent of drugs that show promise in early-phase clinical trials fail to reach the … Why Many Drugs Fail Despite Positive Trial ResultsRead more